Testing time for gene patents. A surprising US court decision highlights the need to modernize gene-patenting practices if patients are to benefit from advances in genetic research.
Nature 2010 April 15; 463(7291): 957
Showing items related by title, author, creator and subject.
Comment on the impact of gene patents and licensing practices on access to genetic testing: lessons from hereditary hemorrhagic telangiectasia. Messner, Donna A.; Pyeritz, Reed E.; Bernhardt, Barbara A. (2010-11)
Impact of gene patents and licensing practices on access to genetic testing and carrier screening for Tay-Sachs and Canavan disease. Colaianni, Alessandra; Chandrasekharan, Subhashini; Cook-Deegan, Robert (2010-04)Genetic testing for Tay-Sachs and Canavan disease is particularly important for Ashkenazi Jews, because both conditions are more frequent in that population. This comparative case study was possible because of different ...
Impact of gene patents and licensing practices on access to genetic testing for inherited susceptibility to cancer: comparing breast and ovarian cancers with colon cancers. Cook-Deegan, Robert; DeRienzo, Christopher; Carbone, Julia; Chandrasekharan, Subhashini; Heaney, Christopher; Conover, Christopher (2010-04)Genetic testing for inherited susceptibility to breast and ovarian cancer can be compared with similar testing for colorectal cancer as a "natural experiment." Inherited susceptibility accounts for a similar fraction of ...